Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) EPS (Weighted Average and Diluted) (2016 - 2026)

Usana Health Sciences has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $0.41 for Q2 2026.

  • Quarterly EPS (Weighted Average and Diluted) fell 16.33% to $0.41 in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $0.48 through Apr 2026, down 73.63% year-over-year, with the annual reading at $0.58 for FY2026, 73.52% down from the prior year.
  • EPS (Weighted Average and Diluted) was $0.41 for Q2 2026 at Usana Health Sciences, up from -$0.09 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $1.73 in Q1 2022 and troughed at -$0.36 in Q3 2025.
  • The 5-year median for EPS (Weighted Average and Diluted) is $0.62 (2023), against an average of $0.65.
  • Year-over-year, EPS (Weighted Average and Diluted) soared 31.82% in 2023 and then tumbled 164.29% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.66 in 2022, then soared by 31.82% to $0.87 in 2023, then crashed by 73.56% to $0.23 in 2024, then tumbled by 256.52% to -$0.36 in 2025, then soared by 213.89% to $0.41 in 2026.
  • Per Business Quant, the three most recent readings for USNA's EPS (Weighted Average and Diluted) are $0.41 (Q2 2026), -$0.09 (Q1 2026), and -$0.36 (Q3 2025).